HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Myeloid-related protein 14 promotes inflammation and injury in meningitis.

AbstractBACKGROUND:
Neutrophilic inflammation often persists for days despite effective antibiotic treatment and contributes to brain damage in bacterial meningitis. We propose here that myeloid-related protein 14 (MRP14), an abundant cytosolic protein in myeloid cells, acts as an endogenous danger signal, driving inflammation and aggravating tissue injury.
METHODS:
The release pattern of MRP14 was analyzed in human and murine cerebrospinal fluid (CSF), as well as in isolated neutrophils. Its functional role was assessed in a mouse meningitis model, using MRP14-deficient mice.
RESULTS:
We detected large quantities of MRP14 in CSF specimens from patients and mice with pneumococcal meningitis. Immunohistochemical analyses and a cell-depletion approach indicated neutrophils as the major source of MRP14. In a meningitis model, MRP14-deficient mice showed a better resolution of inflammation during antibiotic therapy, which was accompanied by reduced disease severity. Intrathecal administration of MRP14 before infection reverted the phenotype of MRP14-deficient mice back to wild type. Moreover, intrathecal injection of MRP14 alone was sufficient to induce meningitis in a Toll-like receptor 4 (TLR4)-CXCL2-dependent manner. Finally, treatment with the MRP14 antagonist paquinimod reduced inflammation and disease severity significantly, reaching levels comparable to those achieved after genetic depletion of MRP14.
CONCLUSIONS:
The present study implicates MRP14 as an essential propagator of inflammation and potential therapeutic target in pneumococcal meningitis.
AuthorsChristina Wache, Matthias Klein, Christian Ostergaard, Barbara Angele, Hans Häcker, Hans-Walter Pfister, Monika Pruenster, Markus Sperandio, Tomas Leanderson, Johannes Roth, Thomas Vogl, Uwe Koedel
JournalThe Journal of infectious diseases (J Infect Dis) Vol. 212 Issue 2 Pg. 247-57 (Jul 15 2015) ISSN: 1537-6613 [Electronic] United States
PMID25605866 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Copyright© The Author 2015. Published by Oxford University Press on behalf of the Infectious Diseases Society of America. All rights reserved. For Permissions, please e-mail: [email protected].
Chemical References
  • ABCC11 protein, human
  • ATP-Binding Cassette Transporters
  • Anti-Bacterial Agents
  • Calgranulin B
  • Chemokine CXCL2
  • Ceftriaxone
Topics
  • ATP-Binding Cassette Transporters (cerebrospinal fluid)
  • Animals
  • Anti-Bacterial Agents (pharmacology, therapeutic use)
  • Calgranulin B (cerebrospinal fluid)
  • Case-Control Studies
  • Ceftriaxone (pharmacology, therapeutic use)
  • Chemokine CXCL2 (biosynthesis)
  • Humans
  • Male
  • Meningitis, Pneumococcal (cerebrospinal fluid, drug therapy, immunology)
  • Mice, Inbred C57BL
  • Mice, Knockout

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: